Michel G D Kester - JoVE Visualize

Showing results (51-60 of 70) with videos related to

Pageof 7

Sort By:

Proceedings of the National Academy of Sciences of the United States of America|November 28, 2022

Human T cells recognize HLA-DP-bound peptides in two orientationsSebastian Klobuch, Jia Jia Lim, Peter van Balen, et al.

Blood|January 20, 2007

Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) geneCornelis A M van Bergen, Michel G D Kester, Inge Jedema, et al.

Proteomics|December 19, 2017

Specific T Cell Responses against Minor Histocompatibility Antigens Cannot Generally Be Explained by Absence of Their Allelic Counterparts on the Cell SurfaceHelena M Bijen, Chopie Hassan, Michel G D Kester, et al.

Blood|January 6, 2017

TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1Lorenz Jahn, Pleun Hombrink, Renate S Hagedoorn, et al.

Journal for Immunotherapy of Cancer|December 9, 2024

DNA barcoded peptide-MHC multimers to measure and monitor minor histocompatibility antigen-specific T cells after allogeneic stem cell transplantationKyra J Fuchs, Marcus Göransson, Michel G D Kester, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2016

Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen in a Splice Variant of ITGB2Margot J Pont, Dyantha I van der Lee, Edith D van der Meijden, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2021

A broad and systematic approach to identify B cell malignancy-targeting TCRs for multi-antigen-based T cell therapyMiranda H Meeuwsen, Anne K Wouters, Lorenz Jahn, et al.

Blood|February 18, 2010

Allo-HLA reactivity of virus-specific memory T cells is commonAvital L Amir, Lloyd J A D'Orsogna, Dave L Roelen, et al.

Proceedings of the National Academy of Sciences of the United States of America|February 26, 2003

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemiaW A Erik Marijt, Mirjam H M Heemskerk, Freke M Kloosterboer, et al.

Cellular and Molecular Life Sciences : CMLS|September 20, 2023

Human CD34+-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8+ T cell and NK cell responses in vitro and in vivoJesper van Eck van der Sluijs, Diede van Ens, Jolanda Brummelman, et al.

Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:

Pageof 7

Proceedings of the National Academy of Sciences of the United States of America|November 28, 2022

Human T cells recognize HLA-DP-bound peptides in two orientationsSebastian Klobuch, Jia Jia Lim, Peter van Balen, et al.

Blood|January 20, 2007

Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) geneCornelis A M van Bergen, Michel G D Kester, Inge Jedema, et al.

Proteomics|December 19, 2017

Specific T Cell Responses against Minor Histocompatibility Antigens Cannot Generally Be Explained by Absence of Their Allelic Counterparts on the Cell SurfaceHelena M Bijen, Chopie Hassan, Michel G D Kester, et al.

Blood|January 6, 2017

TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1Lorenz Jahn, Pleun Hombrink, Renate S Hagedoorn, et al.

Journal for Immunotherapy of Cancer|December 9, 2024

DNA barcoded peptide-MHC multimers to measure and monitor minor histocompatibility antigen-specific T cells after allogeneic stem cell transplantationKyra J Fuchs, Marcus Göransson, Michel G D Kester, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2016

Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen in a Splice Variant of ITGB2Margot J Pont, Dyantha I van der Lee, Edith D van der Meijden, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2021

A broad and systematic approach to identify B cell malignancy-targeting TCRs for multi-antigen-based T cell therapyMiranda H Meeuwsen, Anne K Wouters, Lorenz Jahn, et al.

Blood|February 18, 2010

Allo-HLA reactivity of virus-specific memory T cells is commonAvital L Amir, Lloyd J A D'Orsogna, Dave L Roelen, et al.

Proceedings of the National Academy of Sciences of the United States of America|February 26, 2003

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemiaW A Erik Marijt, Mirjam H M Heemskerk, Freke M Kloosterboer, et al.

Cellular and Molecular Life Sciences : CMLS|September 20, 2023

Human CD34+-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8+ T cell and NK cell responses in vitro and in vivoJesper van Eck van der Sluijs, Diede van Ens, Jolanda Brummelman, et al.

Pageof 7